Project Details
Description
A rollover phase II study testing the biologic activity and safety of AGS-003 in renal cell carcinoma subjects with prolonged response or stable disease and ongoing AGS-003 treatment in protocol AGS-003- 004 or AGS-003-006
| Status | Finished |
|---|---|
| Effective start/end date | 11/1/11 → 11/1/18 |
Funding
- ARGOS THERAPEUTICS, INC
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.